Mean telomere lengths (kilobases) measured in CD19+CD5+, CD19+CD5+CD38+, and CD19+CD5+CD38− fractions
| CLL patient no. . | CD19+ . | CD38+ . | CD38− . |
|---|---|---|---|
| 189 | 6.61 | 5.18 | 4.75 |
| 280 | 5.16 | 8.76 | 4.17 |
| 321 | 4.7 | 4.23 | 3.76 |
| 332 | 0.56 | 0.99 | 0.9 |
| 355 | 3.72 | 3.31 | 4.51 |
| 452 | 1.19 | 1.11 | 2.13 |
| 546 | 7.54 | 8.27 | 8.04 |
| 569 | 2.35 | 2.79 | 1.39 |
| 606 | 3.64 | 3.22 | 3.4 |
| 625 | 1.94 | 2.11 | 1.19 |
| 822 | 2.76 | 2.72 | 4.48 |
| 875 | 3.77 | 4.02 | 3.74 |
| 931 | 4.16 | 3.89 | 4.34 |
| Average ± SE | 3.7 ± 0.56 | 3.9 ± 0.66 | 3.6 ± 0.53 |
| CLL patient no. . | CD19+ . | CD38+ . | CD38− . |
|---|---|---|---|
| 189 | 6.61 | 5.18 | 4.75 |
| 280 | 5.16 | 8.76 | 4.17 |
| 321 | 4.7 | 4.23 | 3.76 |
| 332 | 0.56 | 0.99 | 0.9 |
| 355 | 3.72 | 3.31 | 4.51 |
| 452 | 1.19 | 1.11 | 2.13 |
| 546 | 7.54 | 8.27 | 8.04 |
| 569 | 2.35 | 2.79 | 1.39 |
| 606 | 3.64 | 3.22 | 3.4 |
| 625 | 1.94 | 2.11 | 1.19 |
| 822 | 2.76 | 2.72 | 4.48 |
| 875 | 3.77 | 4.02 | 3.74 |
| 931 | 4.16 | 3.89 | 4.34 |
| Average ± SE | 3.7 ± 0.56 | 3.9 ± 0.66 | 3.6 ± 0.53 |